Extracorporeal membrane oxygenation post lung transplantation

Current Opinion in Organ Transplantation

Volumn 18, Issue 5, 2013, Pages 524-530

  Castleberry, Anthony W ^a   Hartwig, Matthew G ^a   Whitson, Bryan A ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Extracorporeal membrane oxygenation; Lung transplantation; Primary graft dysfunction

Indexed keywords

ADRENALIN; BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; DIAZEPAM; HEPARIN; HIRULOG; HYPERTENSIVE AGENT; INOTROPIC AGENT; LORAZEPAM; MIDAZOLAM; MILRINONE; NARCOTIC AGENT; NITRIC OXIDE; PROPOFOL; PROSTAGLANDIN;

AIRWAY PRESSURE; ANTICOAGULANT THERAPY; ARTIFICIAL VENTILATION; BAROTRAUMA; BLOOD CLOTTING; BREATHING EXERCISE; CANNULA; CANNULATION; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; DRUG DOSE ESCALATION; DRUG SENSITIZATION; EXTRACORPOREAL OXYGENATION; GRAFT FAILURE; GRAFT SURVIVAL; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPOVOLEMIA; LOW DRUG DOSE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MECHANICAL VENTILATOR; MOBILIZATION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT MOBILITY; PHYSIOTHERAPY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIMARY GRAFT DYSFUNCTION; PULMONARY ALLOGRAFT FAILURE; PULMONARY HYPERTENSION; PULSE OXIMETRY; RENAL REPLACEMENT THERAPY; REVIEW; SEDATION; SURVIVAL RATE; SURVIVAL TIME; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT OUTCOME; ALLOTRANSPLANTATION; DEVICES; PROCEDURES; RESPIRATORY FAILURE;

EXTRACORPOREAL MEMBRANE OXYGENATION; GRAFT SURVIVAL; HUMANS; LUNG TRANSPLANTATION; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84888306781     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328365197e     Document Type: Review

References (62)

1. Lefrak EA, Stevens PM, Noon GP, DeBakey ME. Current status of prolonged extracorporeal membrane oxygenation for acute respiratory failure. Chest 1973; 63:773-782.
2. Zapol WM, Snider MT, Schneider RC. Extracorporeal membrane oxygenation for acute respiratory failure. Anesthesiology 1977; 46:272-285.
3. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374:1351-1363.
4. Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med 2011; 365:1905-1914.
5. Bastin AJ, Firmin R. Extracorporeal membrane oxygenation for severe acute respiratory failure in adults: NICE guidance. Heart (British Cardiac Society) 2011; 97:1701-1703.
6. Schuerer DJE, Kolovos NS, Boyd KV, Coopersmith CM. Extracorporeal membrane oxygenation: current clinical practice, coding, and reimbursement. Chest 2008; 134:179-184.
7. Mols G, Loop T, Geiger K, et al. Extracorporeal membrane oxygenation: a tenyear experience. Am J Surg 2000; 180:144-154.
8. Hemmila MR, Rowe SA, Boules TN, et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 2004; 240:595-605. [discussion 605-7]
9. Cypel M, Keshavjee S. Extracorporeal life support as a bridge to lung transplantation. Clin Chest Med 2011; 32:245-251.
10. Diaz-Guzman E, Hoopes CW, Zwischenberger JB. The evolution of extracorporeal life support as a bridge to lung transplantation. ASAIO J 2013; 59:3-10.
11. Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med 2011; 184:159-171.
12. Jackson A, Cropper J, Pye R, et al. Use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature. J Heart Lung Transplant 2008; 27:348-352.
13. Olsson KM, Simon A, Strueber M, et al. Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant 2010; 10:2173-2178.
14. Aigner C, Wisser W, Taghavi S, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg 2007; 31:468-473. [discussion 473-474]
15. Fischer S, Simon AR, Welte T, et al. Bridge to lung transplantation with the novel pumpless interventional lung assist device Nova Lung. J Thorac Cardiovasc Surg 2006; 131:719-723.
16. Christie JD, Kotloff RM, Ahya VN, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171:1312-1316.
17. Meyers BF, Sundt TM, Henry S, et al. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg 2000; 120:20-26.
18. Hartwig MG, Appel JZ, Cantu E, et al. Improved results treating lung allograft failure with veno-venous extracorporeal membrane oxygenation. Ann Thorac Surg 2005; 80:1872-1879. [discussion 1879-80]
19. Dahlberg PS, Prekker ME, Herrington CS, et al. Medium-term results of extracorporeal membrane oxygenation for severe acute lung injury after lung transplantation. J Heart Lung Transplant 2004; 23:979-984.
20. Oto T, Rosenfeldt F, Rowland M, et al. Extracorporeal membrane oxygenation after lung transplantation: evolving technique improves outcomes. Ann Thorac Surg 2004; 78:1230-1235.
21. Marasco SF, Vale M, Preovolos A, et al. Institution of extracorporeal membrane oxygenation late after lung transplantation: a futile exercise? Clin Transplant 2012; 26:E71-E77.
22. Vlasselaers D, Verleden GM, Meyns B, et al. Femoral venoarterial extracorporeal membrane oxygenation for severe reimplantation response after lung transplantation. Chest 2000; 118:559-561.
23. Aigner C, Jaksch P, Mazhar S, et al. Treatment of severe acute lung allograft rejection with OKT3 and temporary extracorporeal membrane oxygenation bridging. Eur J Cardiothorac Surg 2004; 25:184-187.
24. Mason DP, Boffa DJ, Murthy SC, et al. Extended use of extracorporeal membrane oxygenation after lung transplantation. J Thorac Cardiovasc Surg 2006; 132:954-960.
25. Aigner C, Slama A, Hötzenecker K, et al. Clinical ex vivo lung perfusion: pushing the limits. Am J Transplant 2012; 12:1839-1847.
26. Pereszlenyi A, Lang G, Steltzer H, et al. Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension. Eur J Cardiothorac Surg 2002; 21:858-863.
27. Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187:527-534.
28. Hartwig MG, Walczak R, Lin SS, Davis RD. Improved survival but marginal allograft function in patients treated with extracorporeal membrane oxygenation after lung transplantation. Ann Thorac Surg 2012; 93:366-371.
29. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. J Am Med Assoc 1979; 242:2193-2196.
30. Fuehner T, Kuehn C, Hadem J, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012; 185:763-768.
31. Stöhr F, Emmert MY, Lachat ML, et al. Extracorporeal membrane oxygenation for acute respiratory distress syndrome: is the configuration mode an important predictor for the outcome? Interact Cardiovasc Thorac Surg 2011; 12:676-680.
32. Bermudez CA, Rocha RV, Sappington PL, et al. Initial experience with single cannulation for venovenous extracorporeal oxygenation in adults. Ann Thorac Surg 2010; 90:991-995.
33. Reeb J, Falcoz P-E, Santelmo N, Massard G. Double lumen bi-cava cannula for veno-venous extracorporeal membrane oxygenation as bridge to lung transplantation in nonintubated patient. Interact Cardiovasc Thorac Surg 2012; 14:125-127.
34. Hayes D, Kukreja J, Tobias JD, et al. Ambulatory venovenous extracorporeal respiratory support as a bridge for cystic fibrosis patients to emergent lung transplantation. J Cyst Fibros 2012; 11:40-45.
35. Rehder KJ, Turner DA, Hartwig MG, et al. Active rehabilitation during ECMO as a bridge to lung transplantation. Respir Care 2012; 58:1291-1298.
36. Turner DA, Cheifetz IM, Rehder KJ, et al. Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation: a practical approach. Crit Care Med 2011; 39:2593-2598.
37. Mullany DV, Bull TN, Hunt W, et al. Outcomes of the first 30 cases of an adult extracorporeal membrane oxygenation program: strategies to manage the 'learning curve' and implications for intensive care unit risk adjustment models. Crit Care Resusc 2012; 14:119-129.
38. Shekar K, Roberts JA, Ghassabian S, et al. Sedation during extracorporeal membrane oxygenation-why more is less. Anaesth Intensive Care 2012; 40:1067-1069.
39. Mulla H, Lawson G, Von Anrep C, et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion 2000; 15:21-26.
40. Ahsman MJ, Hanekamp M, Wildschut ED, et al. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet 2010; 49:407-419.
41. Wagner D, Pasko D, Phillips K, et al. In vitro clearance of dexmedetomidine in extracorporeal membrane oxygenation. Perfusion 2013; 28:40-46.
42. Hayes D, Galantowicz M, Yates AR, et al. Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction. J Artif Organs 2013; doi: 10.1007/s10047-013-0699-z. [Epub ahead of print]
43. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308.
44. Ranucci M, Ballotta A, Kandil H, et al. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation. Crit Care 2011; 15:R275.
45. Brochard L, Roudot-Thoraval F, Roupie E, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 1998; 158:1831-1838.
46. Hickling KG, Henderson SJ, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990; 16:372-377.
47. Stewart TE, Meade MO, Cook DJ, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group. N Engl J Med 1998; 338:355-361.
48. Modrykamien A, Chatburn RL, Ashton RW. Airway pressure release ventilation: an alternative mode of mechanical ventilation in acute respiratory distress syndrome. Cleve Clin J Med 2011; 78:101-110.
49. Tulman DB, Gupta SD, Tripathi RS, et al. Nine veno-venous ECMO challenges and controversies: a concise perspective. 2013 (in press).
50. Gong MN, Thompson BT, Williams P, et al. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 2005; 33:1191-1198.
51. Netzer G, Shah CV, Iwashyna TJ, et al. Association of RBC transfusion with mortality in patients with acute lung injury. Chest 2007; 132:1116-1123.
52. McCurry KR, Keenan RJ. Controlling perioperative morbidity and mortality after lung transplantation for pulmonary hypertension. Semin Thorac Cardiovasc Surg 1998; 10:139-143.
53. Martin GS, Moss M, Wheeler AP, et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005; 33:1681-1687.
54. Marasco SF, Lukas G, McDonald M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circulation 2008; 17(Suppl 4):S41-S47.
55. Warkentin TE, Greinacher A, Koster A. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required? Ann Thorac Surg 2009; 87:1633-1640.
56. Koster A, Huebler S, Potapov E, et al. Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients. Ann Thorac Surg 2007; 83:72-76.
57. Koster A, Weng Y, Böttcher W, et al. Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT. Ann Thorac Surg 2007; 83:1865-1867.
58. Whitson BA, D'Cunha J. Ex vivo lung perfusion and extracorporeal life support in lung transplantation. Semin Thorac Cardiovasc Surg 2011; 23:176-177.
59. Whitson BA, Tripathi RS, Papadimos TJ. Who truly benefits from extracorporeal membrane oxygenation: a call to develop predictive models. ASAIO J 1992; 59:200-201.
60. Wigfield CH, Lindsey JD, Steffens TG, et al. Early institution of extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation improves outcome. J Heart Lung Transplant 2007; 26:331-338.
61. Bermudez CA, Adusumilli PS, McCurry KR, et al. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long-term survival. Ann Thorac Surg 2009; 87:854-860.
62. Fischer S, Bohn D, Rycus P, et al. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry. J Heart Lung Transplant 2007; 26:472-477.